SCHEMBL19449583

SCHEMBL19449583

COc1cccc(-c2cc(C)n3cnc(C(N)=O)c3n2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.48
MAP4K2 Q12851 1/20 0.48
IRAK4 Q9NWZ3 1/20 0.46
HSD17B10 Q99714 3/20 0.44
KDM4E B2RXH2 3/20 0.43
LMNA P02545 1/20 0.43
ADORA1 P30542 3/20 0.43
ADORA3 P0DMS8 2/20 0.43
ADORA2B P29275 2/20 0.43
ADORA2A P29274 2/20 0.43
CYP3A4 P08684 1/20 0.43
RIPK2 O43353 1/20 0.43
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
PRKDC P78527 1/20 0.42
ATR Q13535 1/20 0.42
TP53 P04637 3/20 0.41
MAPT P10636 2/20 0.41
RORC P51449 1/20 0.41
CSNK2A1 P68400 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19437816 0.90 PIN1 (0.50) MAP4K2HSD17B10KDM4ELMNAADORA1
SCHEMBL19437974 0.86 KDM4E (0.50) HSD17B10KDM4EADORA1ADORA2ACYP3A4
SCHEMBL19449569 0.85 PDGFRB (0.44) MAP4K2HSD17B10KDM4EADORA1ADORA3
SCHEMBL19449434 0.84 HPGDS (0.46) HSD17B10KDM4EADORA1ADORA2AATR
SCHEMBL19449408 0.83 CSNK1E (0.38) IKBKBMAP4K2HSD17B10KDM4EADORA1
SCHEMBL19449573 0.82 TP53 (0.47) HSD17B10KDM4EADORA1ADORA2ACYP3A4
SCHEMBL19438041 0.82 TYRO3 (0.42) MAP4K2HSD17B10KDM4EADORA1ADORA3
SCHEMBL19438266 0.82 HSD17B10 (0.45) MAP4K2HSD17B10KDM4ELMNAADORA1
SCHEMBL19449633 0.81 TGFBR1 (0.43)
SCHEMBL19681732 0.81 MKNK1 (0.44) IKBKBIRAK4HSD17B10KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017176961-A1 IMIDAZO [1,5-A]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS LYSOSOMAL THERAPEUTICS INC. (US) 2017-10-12 WO disclosed